JP2010528583A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528583A5 JP2010528583A5 JP2009519711A JP2009519711A JP2010528583A5 JP 2010528583 A5 JP2010528583 A5 JP 2010528583A5 JP 2009519711 A JP2009519711 A JP 2009519711A JP 2009519711 A JP2009519711 A JP 2009519711A JP 2010528583 A5 JP2010528583 A5 JP 2010528583A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- fragment
- acid sequence
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94328907P | 2007-06-11 | 2007-06-11 | |
| US94349907P | 2007-06-12 | 2007-06-12 | |
| PCT/US2007/073504 WO2008011348A2 (en) | 2006-07-14 | 2007-07-13 | Humanized antibody against amyloid beta |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014026254A Division JP6076274B2 (ja) | 2007-06-11 | 2014-02-14 | アミロイドβに対するヒト化抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010528583A JP2010528583A (ja) | 2010-08-26 |
| JP2010528583A5 true JP2010528583A5 (https=) | 2010-10-07 |
Family
ID=42767991
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009519711A Withdrawn JP2010528583A (ja) | 2007-06-11 | 2007-07-13 | アミロイドβに対するヒト化抗体 |
| JP2014026254A Active JP6076274B2 (ja) | 2007-06-11 | 2014-02-14 | アミロイドβに対するヒト化抗体 |
| JP2016160107A Pending JP2016202186A (ja) | 2007-06-11 | 2016-08-17 | アミロイドβに対するヒト化抗体 |
| JP2018155243A Pending JP2019004892A (ja) | 2007-06-11 | 2018-08-22 | アミロイドβに対するヒト化抗体 |
| JP2020124869A Pending JP2021006025A (ja) | 2007-06-11 | 2020-07-22 | アミロイドβに対するヒト化抗体 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014026254A Active JP6076274B2 (ja) | 2007-06-11 | 2014-02-14 | アミロイドβに対するヒト化抗体 |
| JP2016160107A Pending JP2016202186A (ja) | 2007-06-11 | 2016-08-17 | アミロイドβに対するヒト化抗体 |
| JP2018155243A Pending JP2019004892A (ja) | 2007-06-11 | 2018-08-22 | アミロイドβに対するヒト化抗体 |
| JP2020124869A Pending JP2021006025A (ja) | 2007-06-11 | 2020-07-22 | アミロイドβに対するヒト化抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (5) | JP2010528583A (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT396939B (de) * | 1990-05-29 | 1993-12-27 | Alois Dipl Ing Dr Jungbauer | Komplexes virales antigen von hiv-1 bindendes rekombinantes protein |
| US5837822A (en) * | 1992-01-27 | 1998-11-17 | Icos Corporation | Humanized antibodies specific for ICAM related protein |
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| NZ540564A (en) * | 1999-11-29 | 2007-04-27 | Neurochem Int Ltd | Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases |
| BRPI0108676B8 (pt) * | 2000-02-24 | 2021-05-25 | Lilly Co Eli | anticorpos humanizados que sequestram peptídeo amilóide beta e seus usos no tratamento de condições caracterizadas por formação de placas amiloides, bem como composição farmacêutica que compreende os referidos anticorpos |
| DE60312639T2 (de) * | 2002-01-18 | 2007-11-29 | Pierre Fabre Médicament | Antikörper gegen igf-ir und ihre verwendungen |
| AR038568A1 (es) * | 2002-02-20 | 2005-01-19 | Hoffmann La Roche | Anticuerpos anti-a beta y su uso |
| AU2005269940A1 (en) * | 2004-07-02 | 2006-02-09 | Northwestern University | Monolocal antibodies that target pathological assemblies of amyloid beta (Abeta) |
| TWI309240B (en) * | 2004-09-17 | 2009-05-01 | Hoffmann La Roche | Anti-ox40l antibodies |
| EP1838349A1 (en) * | 2004-12-15 | 2007-10-03 | Neuralab, Ltd. | Amyloid beta antibodies for use in improving cognition |
| TWI372763B (en) * | 2005-06-17 | 2012-09-21 | Wyeth Llc | Methods of purifying anti a beta antibodies |
| RU2432362C2 (ru) * | 2005-11-30 | 2011-10-27 | Эбботт Лэборетриз | Моноклональные антитела и их применения |
| US20090232801A1 (en) * | 2007-05-30 | 2009-09-17 | Abbot Laboratories | Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof |
-
2007
- 2007-07-13 JP JP2009519711A patent/JP2010528583A/ja not_active Withdrawn
-
2014
- 2014-02-14 JP JP2014026254A patent/JP6076274B2/ja active Active
-
2016
- 2016-08-17 JP JP2016160107A patent/JP2016202186A/ja active Pending
-
2018
- 2018-08-22 JP JP2018155243A patent/JP2019004892A/ja active Pending
-
2020
- 2020-07-22 JP JP2020124869A patent/JP2021006025A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505415A5 (https=) | ||
| CA2853531C (en) | Humanized antibodies that recognize alpha-synuclein | |
| JP6342333B2 (ja) | α−シヌクレインを認識するヒト化抗体 | |
| KR100767146B1 (ko) | Ａβ 펩티드를 격리시키는 인간화 항체 | |
| CN103339146B (zh) | 人抗tau抗体 | |
| RU2009104769A (ru) | Гуманизированное антитело к амилоиду бета | |
| JP2010530744A5 (https=) | ||
| RU2010100342A (ru) | Гуманизированные антитела к амилоиду бета | |
| MX2008012223A (es) | Anticuerpos selectivos de protofibrilo mejorados y su uso. | |
| US11440953B2 (en) | Anti-abeta antibodies | |
| CA3244753A1 (en) | THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISORDER | |
| RU2013115283A (ru) | Гуманизированное антитело к амилоиду бета | |
| JP2010528583A5 (https=) | ||
| EP4655319A1 (en) | Methods of treating neurological disorders with anti-abeta antibodies | |
| KR102655944B1 (ko) | 항-아밀로이드 베타 항체 및 이의 사용 방법 | |
| WO2025228316A1 (en) | Anti-n3pglu amyloid beta antibodies and uses thereof | |
| WO2025228315A1 (en) | Anti-n3pglu amyloid beta antibodies and uses thereof | |
| AU2024332186A1 (en) | Therapeutic agent for neurodegenerative diseases |